VEGF-A in Cardiomyocytes and Heart Diseases
Top Cited Papers
Open Access
- 25 July 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (15), 5294
- https://doi.org/10.3390/ijms21155294
Abstract
The vascular endothelial growth factor (VEGF), a homodimeric vasoactive glycoprotein, is the key mediator of angiogenesis. Angiogenesis, the formation of new blood vessels, is responsible for a wide variety of physio/pathological processes, including cardiovascular diseases (CVD). Cardiomyocytes (CM), the main cell type present in the heart, are the source and target of VEGF-A and express its receptors, VEGFR1 and VEGFR2, on their cell surface. The relationship between VEGF-A and the heart is double-sided. On the one hand, VEGF-A activates CM, inducing morphogenesis, contractility and wound healing. On the other hand, VEGF-A is produced by CM during inflammation, mechanical stress and cytokine stimulation. Moreover, high concentrations of VEGF-A have been found in patients affected by different CVD, and are often correlated with an unfavorable prognosis and disease severity. In this review, we summarized the current knowledge about the expression and effects of VEGF-A on CM and the role of VEGF-A in CVD, which are the most important cause of disability and premature death worldwide. Based on clinical studies on angiogenesis therapy conducted to date, it is possible to think that the control of angiogenesis and VEGF-A can lead to better quality and span of life of patients with heart disease.Keywords
This publication has 195 references indexed in Scilit:
- Direct Comparison of Different Stem Cell Types and Subpopulations Reveals Superior Paracrine Potency and Myocardial Repair Efficacy With Cardiosphere-Derived CellsJournal of the American College of Cardiology, 2012
- Intraplaque haemorrhages as the trigger of plaque vulnerabilityEuropean Heart Journal, 2011
- VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heartCardiovascular Research, 2011
- Heme Oxygenase-1/Carbon Monoxide Induces Vascular Endothelial Growth Factor Expression via p38 Kinase-dependent Activation of Sp1Published by Elsevier BV ,2011
- Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heartProceedings of the National Academy of Sciences of the United States of America, 2011
- Vascular endothelial growth factor (VEGF)-A: Role on cardiac angiogenesis following myocardial infarctionMicrovascular Research, 2010
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Thin-Walled Microvessels in Human Coronary Atherosclerotic Plaques Show Incomplete Endothelial JunctionsJournal of the American College of Cardiology, 2009
- Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesisExperimental Cell Research, 2005
- The biology of VEGF and its receptorsNature Medicine, 2003